YKL 06-061

CAS No. 2172617-15-9

YKL 06-061( YKL06-061 )

Catalog No. M13473 CAS No. 2172617-15-9

YKL 06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor with IC50 of 6.56/1.77/20.5 nM for SIK1/2/3, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 77 In Stock
5MG 67 In Stock
10MG 119 In Stock
25MG 204 In Stock
50MG 290 In Stock
100MG 436 In Stock
200MG 626 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YKL 06-061
  • Note
    Research use only, not for human use.
  • Brief Description
    YKL 06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor with IC50 of 6.56/1.77/20.5 nM for SIK1/2/3, respectively.
  • Description
    YKL 06-061 is a potent, selective, second-generation salt-inducible kinase (SIK) inhibitor with IC50 of 6.56/1.77/20.5 nM for SIK1/2/3, respectively; inhibits only one kinase FRK (IC50=1.1 nM), more strongly than SIKs, in a panel of 468 human kinases; dose-dependently increases MITF mRNA expression in human melanoma cells; induces significant pigmentation in Mc1r-deficient mice and normal human skin.
  • In Vitro
    YKL 06-061 yields a dose-dependent increase in MITF mRNA expression. :RT-PC RCell Line:UACC62 human melanoma cells, and UACC257 human melanoma cells.Concentration:0-4 μM (UACC62); 0-16 μM (UACC257).Incubation Time:3 hours.Result:Yielded a dose-dependent increase in MITF mRNA expression.
  • In Vivo
    ——
  • Synonyms
    YKL06-061
  • Pathway
    Autophagy
  • Target
    SIK
  • Recptor
    SIK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2172617-15-9
  • Formula Weight
    527.673
  • Molecular Formula
    C30H37N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 62.5 mg/mL 118.45 mM; H2O : < 0.1 mg/mL
  • SMILES
    O=C1N(C2CCC2)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4OC)=NC=C3CN1C6=C(C)C=CC=C6C
  • Chemical Name
    Pyrimido[4,5-d]pyrimidin-2(1H)-one,1-cyclobutyl-3-(2,6-dimethylphenyl)-3,4-dihydro-7-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mujahid N, et al. Cell Rep. 2017 Jun 13;19(11):2177-2184.
molnova catalog
related products
  • GLPG3970

    GLPG3970 GLPG3970 is a novel orally available selective dual SIK2/SIK3 inhibitor.GLPG3970 has potential anti-inflammatory activity for the study of autoimmune diseases.

  • YKL-05-099

    YKL-05-099 (YKL 05-099) is a novel potent, selective pan-SIK inhibitor with IC50 of 10, 40 and 30 nM for SIK1, 2 and 3, respectively.

  • Dp44mT

    Dp44mT, a effective iron chelator, has selective antitumor activity.